Quick Takeaways
- T. Rowe Price Investment Management, Inc. filed SCHEDULE 13G/A for APPLIED THERAPEUTICS INC COMMON STOCK (APLT).
- Disclosed ownership: 13%.
- Date of event: 30 Jun 2025.
T. Rowe Price Investment Management, Inc. - 30 Jun 2025 SCHEDULE 13G/A Report for APPLIED THERAPEUTICS INC COMMON STOCK (APLT)
- Filing Manager
- T. Rowe Price Investment Management, Inc.
- Reporting Manager
- T. Rowe Price Investment Management, Inc.
- Symbol
- APLT
- Shares outstanding
- 141,545,379 shares
- Disclosed Ownership
- 18,683,990 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 12:12:13 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 07 May 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"T. Rowe Price Investment Management, Inc. disclosed 13% ownership in APPLIED THERAPEUTICS INC COMMON STOCK (APLT) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 07 May 2025.
- Current filing was accepted on 14 Aug 2025, 12:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 13% | 18,683,990 | 18,683,990 | 0 | Ellen York | Vice President |